PARSIPPANY, N.J., March 8, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX), an emerging specialty pharmaceutical company, today announced that David Stack, president and chief executive officer, is scheduled to present at the Barclays Capital 2011 Global Healthcare Conference on Thursday, March 17, 2011, at 9:30 a.m. EDT being held at the Loews Miami Hotel in Miami, FL. Mr. Stack is expected to present an overview of the company.
A live audio webcast of Pacira's presentation can be accessed by visiting the investors section of the company's website at investor.pacira.com. A replay of the webcast will be archived on the Pacira website for two weeks following the presentation date.
About PaciraPacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, manufacture, and commercialization of novel pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. The company's most advanced investigational product candidate, EXPAREL, a bupivacaine-based product, has completed Phase 3 clinical development for postoperative analgesia by infiltration. EXPAREL consists of bupivacaine encapsulated in DepoFoam, which is designed to address the limitations of widely used medications by enhancing their dosing and/or administration profile. Additional information about Pacira is available at www.pacira.com.Contacts:Company Contact:Pacira Pharmaceuticals, Inc.James S. Scibetta, 973-254-3560orInvestor Contact:Pure Communications Inc.Jennifer Beugelmans, 646-596-7473
|SOURCE Pacira Pharmaceuticals, Inc.|
Copyright©2010 PR Newswire.
All rights reserved